Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| R Reo.DevCompany profile AI-native GTM platform for companies selling to engineering and technical teams AI-native GTM platform for companies selling to engineering and technical teams | $11.3M | Series A | Developer tools | United States | Investors | |
| E EmergentCompany profile AI software creation platform for building full-stack, production-ready web and mobile applications |
Ranked by rounds participated in · All time
Metriport, Arintra, Multiplier
Transfyr, General Intuition, Castelion
Rillet, Castelion, Hadrian
SiFly Aviation, Apollo Atomics, Hopscotch Primary Care
Higgsfield, Lovable, Cambridge Aerospace
Explore published rounds while the next edition is being prepared.
AI software creation platform for building full-stack, production-ready web and mobile applications
| $130M |
| Series CSeries C+ |
| Enterprise software |
| India |
| Investors |
| I AI-powered SaaS platform for production-chain management | Undisclosed | Growth | Logistics | United States | Investors |
| P Technology-enabled cue sports company | $55M | Growth | Consumer | United Kingdom | Investors |
| BS Platform for agentic cybersecurity work | $13M | Seed | Cybersecurity | United States | Investors |
| A ApalumaCompany profile Apaluma unifies government regulatory records into a searchable, location‑mapped platform Apaluma unifies government regulatory records into a searchable, location‑mapped platform | $5.6M | Seed | Enterprise software | United States | Investors |
| S Recycles nylon, producing pellets for clothing supply chain | $30M | Series A | Climate tech | France | Investors |
| BH Bunkerhill HealthCompany profile Bunkerhill Health builds an agentic AI platform for health systems to turn their ideas into reality Bunkerhill Health builds an agentic AI platform for health systems to turn their ideas into reality | $25M | Series B | Healthtech | United States | Investors |
| BE Blue Energy develops financeable, prefabricated nuclear power plants | Undisclosed | StrategicUndisclosed | Climate tech | United States | Investors |
| TB Trellis BioscienceCompany profile Developing native human monoclonal antibodies to treat intractable infectious diseases Developing native human monoclonal antibodies to treat intractable infectious diseases | $9M | Series CSeries C+ | Biotech | United States | Investors |